20/25 Logo 5032 (Hydrochlorothiazide and lisinopril 25 mg / 20 mg)
Pill imprint 20/25 Logo 5032 has been identified as Hydrochlorothiazide and lisinopril 25 mg / 20 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 25 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 20/25 Logo 5032 (Hydrochlorothiazide and lisinopril 25 mg / 20 mg)
- 25 mg / 20 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|23490-5822||Palmetto State Pharmaceuticals Inc (repackager)|
|16590-0309||Stat RX USA LLC (repackager)|
|43063-0130||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/lisinopril
- Hydrochlorothiazide and lisinopril
- Lisinopril and hydrochlorothiazide (Advanced Reading)